BusinessModerna Stock Drops After FDA Declines Review of mRNA Flu VaccineBy Riza DagocFeb 11, 2026, 1:30 AM UTC
BusinessInnovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology DealBy Riza DagocFeb 9, 2026, 5:22 AM UTC
BusinessHims & Hers Halts Compounded Semaglutide Pill After FDA WarningBy Riza DagocFeb 8, 2026, 12:59 AM UTC
HealthWeight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer MarketingBy Riza DagocFeb 8, 2026, 12:42 AM UTC
GovernanceFDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety ConcernsBy Riza DagocFeb 7, 2026, 3:05 AM UTC
HealthTrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most AmericansBy Riza DagocFeb 7, 2026, 2:44 AM UTC
BusinessNovo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising CompetitionBy Riza DagocFeb 4, 2026, 2:05 AM UTC
HealthRFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community BacklashBy Riza DagocJan 29, 2026, 1:35 AM UTC
